ChiCTR2500115868
尚未开始
/
/
/
2025-12-31
/
/
Fibromyalgia
Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
Objective: We would like to show that 1) combination of GABA and butyrate as a supplement and 2) GABA-butyrate producing synbiotics can reduce pain in patients with fibromyalgia better than placebo. With the effects on vagus nerves and enteric nervous system, GABA-butyrate or its producing synbiotics may also improve the functional outcomes of fibromyalgia patients with the interference of pain.
随机平行对照
Ⅱ期
Block randomization will be used in our trial. We are aware that it is a multicentre trial involving 7 pain centres in Hong Kong in which the inter-centre variability is unlikely to be negligible. The randomization will be stratified in each center so to have similar distribution of each study arm in each center
This is a double-blinded study in which both the assessors and the patients will be blinded. The bottles, though not completely identical between different arms, the content would not be distinguishable by the appearance of the bottles. Labelling will show only the study arms and bottle A or B respectively.
Peter Hung Pain Research Institute
/
50
/
2026-01-02
2028-03-31
/
1. Patients who are >=18 years old, under care of the pain clinics in the collaborating hospitals; 2. FM has been diagnosed according to the revised 2016 American College of Rheumatology (ACR) Preliminary Diagnostic Criteria for FM, and 3. Able to provide written informed consent and agree to adhere to the trial protocol and follow-up schedule for 12 months, including the 3-monthly follow-up for half a year and a follow-up at 1 year.；
请登录查看1. Pregnant; 2. Known history of allergic reactions to maize, probiotics or prebiotics; 3. Using prebiotics and/ or probiotics within 15 days before enrolment; 4. Immunocompromised with (a) active chemotherapy or immunotherapy or (b) chronic leukopenia (with cell count < 4x10^9/L) within 3 months of enrolment.；
请登录查看The Chinese University of Hong Kong
/
基石药业官微2026-02-16
一度医药2026-02-16
药明康德2026-02-16
医麦客2026-02-16
良医汇肿瘤资讯2026-02-15
国际眼科时讯2026-02-15
医麦客2026-02-15
药时空2026-02-15
石药集团2026-02-14
江苏康宁杰瑞生物制药有限公司2026-02-14
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
